James C. Mullen

Jim Mullen 2016 (headshot)

Editas Medicine announces the appointment of James C. Mullen as Chief Executive Officer, effective February 15, 2021.

Format

JPEG

Quelle:

Editas Medicine, Inc.

Downloads